Elevation of fetal hemoglobin is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC leukemia group, gimema and german MDS study groupJulia Stomper, Michael Lübbert, Mario Luppi et al.|Blood|2025Cited by 0